Skip to main content
OpenTrials

Clinical trial condition

Urological Manifestations

Explore clinical trials studying Urological Manifestations. Study availability and eligibility vary by location and protocol.

2,297 public trials 272 recruiting studies
Refine in advanced search Browse all conditions

Urological Manifestations trial results

Completed

Post Market Study Of Single Incision Sling Versus Transobturator Sling for Stress Urinary Incontinence

NCT01784588

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +10 more
Locations
  • Cedars Sinai Medical Center Beverly Hills, California, United States
  • Loma Linda University Medical Center Loma Linda, California, United States
  • Scripps Clinic Carmel Valley San Diego, California, United States
  • Norwalk Hospital Norwalk, Connecticut, United States
View all 23 locations
View Trial Details
Completed

GTx-024 as a Treatment for Stress Urinary Incontinence in Women

NCT02658448

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +10 more
Locations
  • William Beaumont Hospital Royal Oak, Michigan, United States
  • Urologic Consultants of Southeastern Pennsylvania Bala-Cynwyd, Pennsylvania, United States
  • Penn Center for Continence and Pelvic Health, University of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Effect and Safety Of Detrol LA In Men With Overactive Bladder Symptoms With Or Without Bladder Outlet Obstruction

NCT00147654

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +8 more
Locations
  • Pfizer Investigational Site Birmingham, Alabama, United States
  • Pfizer Investigational Site Homewood, Alabama, United States
  • Pfizer Investigational Site Tucson, Arizona, United States
  • Pfizer Investigational Site Anaheim, California, United States
View all 95 locations
View Trial Details
Completed

Effect of Detrol LA on Overactive Bladder Symptoms, Sexual Quality of Life and Sexual Function in Women

NCT00143481

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +8 more
Locations
  • Pfizer Investigational Site Chandler, Arizona, United States
  • Pfizer Investigational Site Phoenix, Arizona, United States
  • Pfizer Investigational Site Little Rock, Arkansas, United States
  • Pfizer Investigational Site Berkeley, California, United States
View all 58 locations
View Trial Details
Completed

A Study to Measure the Effect of Tolterodine Extended Release on the Thickness of the Bladder Wall in Patients With Overactive Bladder

NCT00137397

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +8 more
Locations
  • Pfizer Investigational Site Blackburn, Lancashire, United Kingdom
  • Pfizer Investigational Site Harrow, Middx, United Kingdom
  • Pfizer Investigational Site Oxford, Oxfordshire, United Kingdom
  • Pfizer Investigational Site Livingston, West Lothian, United Kingdom
View Trial Details
Completed

Evaluate Efficacy and Safety Of Tolterodine Extended Release Capsule Compared With Tolterodine Immediate Release Tablet

NCT00139724

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +8 more
Locations
  • Pfizer Investigational Site Beijing, Beijing Municipality, China
  • Pfizer Investigational Site Beijing, Beijing Municipality, China
  • Pfizer Investigational Site Huangzhou, Zhejiang, China
  • Pfizer Investigational Site Beijing, China
View Trial Details
Completed

Effect Of Detrol LA With Behavioral Intervention In Overactive Bladder Subjects Dissatisfied With Recent OAB Medication.

NCT00230789

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +8 more
Locations
  • Pfizer Investigational Site Phoenix, Arizona, United States
  • Pfizer Investigational Site Sun Lakes, Arizona, United States
  • Pfizer Investigational Site Little Rock, Arkansas, United States
  • Pfizer Investigational Site Beverly Hills, California, United States
View all 51 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy of Tolterodine on Specific Symptoms in Adult Patients With Overactive Bladder.

NCT00645281

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +8 more
Locations
  • Pfizer Investigational Site Birmingham, Alabama, United States
  • Pfizer Investigational Site Birmingham, Alabama, United States
  • Pfizer Investigational Site Birmingham, Alabama, United States
  • Pfizer Investigational Site Huntsville, Alabama, United States
View all 96 locations
View Trial Details

Related conditions